Europe’s neurologists join forces in the European Academy of Neurology

Europe will now have just one international neurological association. The two European societies – the EFNS and the ENS – have merged during the Joint Congress of European Neurology in Istanbul to create the new European Academy of Neurology (EAN). Prof Günther Deuschl from Kiel, Germany, was elected the first President of the new organisation.

Günther Deuschl is Professor of Neurology and Chairman of the Department of...
Günther Deuschl is Professor of Neurology and Chairman of the Department of Neurology, Christian-Albrechts-Universität, Kiel

Günther Deuschl is Professor of Neurology and Chairman of the Department of Neurology, Christian-Albrechts-Universität, Kiel. His special interests include deep brain stimulation and tremor. „I am sure that this merger will move European neurology into a pole position”, the new EAN President said. "We want to stand together to fulfil the mission of this new society. It includes taking the lead in terms of neurological practice and education on this continent and defining standards of patient care in Europe, a region which is underway to harmonizing its health systems. This society also has a huge potential when it comes to promoting scientific progress in neurology and neurosciences in general.”

The General Assembly of the EAN also elected the following officers to serve on the board of the new organisation:

Vice President:
Prof Franz Fazekas, Graz, Austria

Secretary General:
Prof Didier Leys, Lille, France

Treasurer:
Prof Marianne de Visser, Amsterdam, The Netherlands

Chair Scientific Committee:
Prof Antonio Federico, Siena, Italy

Chair Liaison Committee:
Prof David Vodusek, Ljubljana, Slovenia

Member at large:
Prof Per Soelberg Sorensen, Kopenhagen, Denmark

The first EAN Congress is scheduled to take place in Berlin, Germany in June 2015.

04.06.2014

More on the subject:

Related articles

Photo

News • Polygenic risk assessment

Sleep study for early detection of Alzheimer's risk

New research suggests that subtle markers during sleep – such as nocturnal micro-awakenings – may yield early clues to a greater genetic risk of developing Alzheimer’s disease.

Photo

News • Biomarker panel

Seven proteins could lead to better blood tests for Alzheimer’s

More biomarkers for better insights on Alzheimer's disease: a new study explores how a panel of seven proteins could help predict disease progression and inform more accurate treatment choices.

Photo

News • Neuroimaging

Alzheimer’s: MRI metric identifies early white matter damage

A diffusion MRI metric can detect changes in white matter tracts not visible on conventional MRI – this could help identify early abnormalities in the brain associated with Alzheimer’s disease.

Subscribe to Newsletter